Communicating Objective Risk for Personalized Decision Making About Mammography

July 20, 2017 updated by: University of Pennsylvania
The purpose of this study is to test the effects of objective risk information about breast cancer and mammography outcomes using a randomized control trial. Women between the ages of 35 and 49 will receive information about their personal risk for breast cancer and be randomly assigned to receive data about a woman who should be screened, data about the potential outcomes of screening, or data about breast cancer deaths. Two presentation formats will be tested and compared.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study will compare alternative strategies for the presentation of individualized information about the risks and benefits of mammography screening. The purpose of this study is to understand how objective risk information influences outcomes including behavioral intentions, attitudes about mammography, and emotional responses.

After participants view objective risk information, a post-test survey will measure outcome variables including behavioral intentions, knowledge, and emotional responses.

After reading information based on their condition, study participants will be asked to complete a series of questions to measure their reactions based on their condition. Specifically, the investigators will be measuring the following dependent variables (primary outcomes): behavioral intentions to receive mammograms, attitudes about mammography, subjective norms about mammography and breast cancer screening, knowledge about mammography outcomes and screening recommendations, and emotional responses to the material including psychological reactance. These outcomes will be measured using self-reported questionnaire items.

In this project, the investigators will compare alternative communication strategies to determine which strategy or strategies result in the greatest level of understanding. The investigators also will examine if the various strategies differentially affect the primary outcomes listed above.

Study Type

Interventional

Enrollment (Actual)

1560

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 49 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Adult women between the ages of 35 and 49 will be invited to participate in this study.

Exclusion Criteria:

  • Women who have been previously diagnosed with breast cancer or have tested positive for the breast cancer gene will not be included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group 1: pre/post-test
Group receives pre and post test questions only.
Experimental: Control group 2: tool and pre/post-test
Group receives decision tool without personalized information. (Behavioral: Decision Aid)
Experimental: Gail score in a percentage format
Group receives Gail score in a percentage format. (Behavioral: Decision Aid)
Experimental: Gail score in a frequency format
Group receives Gail score in a frequency format. (Behavioral: Decision Aid)
Experimental: Frequency + Average 50 year old
Group receives Gail score in a frequency format as well as information about risk of breast cancer for the average 50 year old woman. (Behavioral: Decision Aid)
Experimental: Frequency + Mammography Data
Group receives Gail score in a frequency format as well as information about the risks of mammography. (Behavioral: Decision Aid)
Experimental: Frequency + Mortality Data
Group receives Gail score in a frequency format as well as information about mortality benefit of mammography. (Behavioral:Decision Aid)
Experimental: Frequency + Avg 50 year old + Mamm Data + Mortality Data
Group receives Gail score in a frequency format as well as information about breast cancer risk for the average 50 year old woman, information about the risks of mammography, risk of breast cancer for the average 50 year old woman, and information about the mortality benefit associated with mammography. (Behavioral: Decision Aid)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Behavioral intentions to get a mammogram
Time Frame: immediately following intervention (time 0)
All participants will be asked to report their behavioral intentions to obtain mammograms in their 40s and at age 50.
immediately following intervention (time 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitude about mammography
Time Frame: immediately following intervention (time 0)
Participants will be asked to report their attitudes about mammography (i.e., is a mammogram useful, harmful, etc.)
immediately following intervention (time 0)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injunctive and descriptive norms about mammography
Time Frame: immediately following intervention (time 0)
Participants will be asked to report their perceived norms about mammography, what they think important others would expect them to do and what they think other women their age or older are doing.
immediately following intervention (time 0)
Decisional satisfaction
Time Frame: immediately following intervention (time 0)
This variable assesses how satisfied participants feel about making a decision about mammography given the information they have been provided. Items include, "The information in the decision aid made me feel the choice to get a mammogram is being taken away from me by the groups that make screening recommendations."
immediately following intervention (time 0)
Risk perception
Time Frame: immediately before and after intervention (time 0)
This variable includes perceived severity and perceived susceptibility of breast cancer. Items include, "What is the chance that an average 40-49 year old woman will develop breast cancer in the next 10 years? Please choose a number between 0 (no chance of breast cancer) and 100 (definitely will get breast cancer)."
immediately before and after intervention (time 0)
Clarity of the information being presented
Time Frame: immediately following intervention (time 0)
These items assess how easy it is for participants to understand the numerical information that is provided in the decision aid.
immediately following intervention (time 0)
Credibility of the information
Time Frame: immediately following intervention (time 0)
These items measure the perceived trustworthiness, credibility, and accuracy of the information provided in the decision aid. Items include, "How credible did you find the information presented in the decision aid?"
immediately following intervention (time 0)
Emotional reactions
Time Frame: immediately following intervention (time 0)
The outcome includes measures of psychological reactance, anger, and fear that may be possible reactions to the decision aid. Items include, "How much do each of the following words (i.e., angry, worried) describe how you felt while reading the decision aid?"
immediately following intervention (time 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joseph N Cappella, PhD, University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

December 18, 2012

Study Completion (Actual)

December 18, 2012

Study Registration Dates

First Submitted

August 28, 2012

First Submitted That Met QC Criteria

September 17, 2012

First Posted (Estimate)

September 18, 2012

Study Record Updates

Last Update Posted (Actual)

July 21, 2017

Last Update Submitted That Met QC Criteria

July 20, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 816186

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Decision Aid

Subscribe